Buchumschlag

Racial and ethnic disparities in post‐liver transplant outcomes for patients with acute‐on‐chronic liver failure: An analysis of the UNOS database

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	David Uihwan Lee, Mohammed Rifat Shaik, Kuntal Bhowmick, Gregory Hongyuan Fan, Kimberly Schuster, Abdul Yousaf, Mohamed Refaat, Nishat Anjum Shaik, Ki Jung Lee, Sarah Yang, Aneesh Bahadur, Nathalie H. Urrunaga
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
von: Jung Eun Park, et al.
Veröffentlicht: (2024)

Editorial: Paradox of liver fat content in the spectrum of non‐alcoholic fatty liver disease
von: Sung Won Chung, et al.
Veröffentlicht: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
von: Jian Wang, et al.
Veröffentlicht: (2024)

UK guideline on the transition and management of childhood liver diseases in adulthood
von: Deepak Joshi, et al.
Veröffentlicht: (2024)

Identification of four novel acute‐on‐chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methods
von: Nipun Verma, et al.
Veröffentlicht: (2024)

Editorial: Enhancing frailty assessment in liver transplantation candidates—The role of the Duke Activity Status Index in predicting mortality and guiding prehabilitation
von: Sara J. Harris, et al.
Veröffentlicht: (2024)

Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests?
von: C. Gaume, et al.
Veröffentlicht: (2024)

Editorial: Muscles at the expense of liver injury. Is it worth it?
von: C. Stephens
Veröffentlicht: (2024)

Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
von: Nobuharu Tamaki, et al.
Veröffentlicht: (2024)

Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality
von: Nobuharu Tamaki, et al.
Veröffentlicht: (2024)

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury
von: Mar Riveiro‐Barciela, et al.
Veröffentlicht: (2024)

Editorial: The future of managing drug induced liver injury
von: Amanda Nicoll
Veröffentlicht: (2024)

Review article: Oesophageal disorders in chronic liver disease
von: Francisco Idalsoaga, et al.
Veröffentlicht: (2024)

Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
von: Yewan Park, et al.
Veröffentlicht: (2024)

Editorial: Enhancing frailty assessment in liver transplantation candidates—The role of the Duke Activity Status Index (DASI) in predicting mortality and guiding prehabilitation. Authors' reply
von: Matthew J. Armstrong, et al.
Veröffentlicht: (2024)

Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests? Authors' reply
von: Maria Gabriela Fernandes Dezan, et al.
Veröffentlicht: (2024)

Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis
von: Shusuke Kumazaki, et al.
Veröffentlicht: (2024)

Letter: Reflections on the significance of myokines in alcohol‐associated liver disease
von: Yaomin Wang, et al.
Veröffentlicht: (2024)

Editorial: Crystalising the burden of steatotic liver disease—Authors' reply
von: Carolin V. Schneider, et al.
Veröffentlicht: (2024)

Letter: Zinc and selenium—Potential biomarkers for chronic liver disease?
von: Zhuo Li, et al.
Veröffentlicht: (2024)

Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes
von: Xianhua Mao, et al.
Veröffentlicht: (2024)

The impact of macro‐ and micro‐steatosis on the outcomes of patients who undergo liver transplant: Analysis of the UNOS‐STAR database
von: David Uihwan Lee, et al.
Veröffentlicht: (2024)

Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
von: Pojsakorn Danpanichkul, et al.
Veröffentlicht: (2024)

Myokines are associated with progression, course and mortality in alcohol‐associated liver disease
von: Parminder Kaur, et al.
Veröffentlicht: (2024)

Impacts of glucagon‐like peptide‐1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction‐associated steatotic liver disease cirrhosis and type 2 diabetes
von: Mohamed I. Elsaid, et al.
Veröffentlicht: (2024)

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States
von: Richie Manikat, et al.
Veröffentlicht: (2024)

Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases
von: Ivan Arcari, et al.
Veröffentlicht: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
von: Nina Dominik, et al.
Veröffentlicht: (2024)

Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world
von: Abdel‐Aziz Shaheen, et al.
Veröffentlicht: (2024)

Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
von: Pojsakorn Danpanichkul, et al.
Veröffentlicht: (2024)

Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States
von: Donghee Kim, et al.
Veröffentlicht: (2024)

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
von: Jannis Kountouras, et al.
Veröffentlicht: (2024)

Characterisation of an outbreak of acute liver injury after ingestion of plant‐based food supplement
von: Gina Choi, et al.
Veröffentlicht: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice
von: Basile Njei, et al.
Veröffentlicht: (2024)

Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply
von: Manya Prasad, et al.
Veröffentlicht: (2024)

Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease
von: Nabil Noureddin, et al.
Veröffentlicht: (2024)

Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
von: Carolin V. Schneider, et al.
Veröffentlicht: (2024)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
von: Stuart McPherson, et al.
Veröffentlicht: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
von: Eunice X. X. Tan, et al.
Veröffentlicht: (2024)

Editorial: Sounding the alarm—The rising global burden of adolescent and young adult alcohol‐related liver disease
von: Victoria T. Kronsten, et al.
Veröffentlicht: (2024)